Clinical and epidemiological profile of pancreatic cancer in Paraná between 2010 and 2018




Pancreatic cancer; Epidemiology; Oncology; Smoking.


Pancreatic cancer represents the 5th neoplasm that most kills women and the 7th with the highest mortality among men in Brazil. Despite being in 10th place in the ranking of cancer incidence in the country, its high morbimortality and increasing rates project it as a leading cause of death by 2050. The absence of specific symptoms, effective screening strategies and Competent treatments make pancreatic cancer a public health challenge. Risk factors may include advanced age, obesity, alcoholism, diabetes and genetic predisposition syndromes, but studies regarding these are still insufficient to characterize this profile. The objectives of this study were to characterize the clinical profile of patients with pancreatic cancer, helping to delineate risk factors for neoplasia. Data were obtained from the INCA hospital cancer registry platform, selecting patients with pancreatic cancer registered between 2010 and 2018 treated in Paraná, analyzing the characteristics: gender, ethnicity, educational level, age group, tobacco consumption and of alcohol, anatomopathological sublocation. The most prevalent non-modifiable characteristics were white, incomplete primary education, male, age group 60-64 years; modifiable variables, never smokers and never drinkers; the head of the organ was the most affected region. There was also a high rate of cases without information about the characteristics in the hospital records. From the characterization of the patients, it will be possible to help guide strategies for identification, support and treatment of pancreatic cancer.


Chen, X.-Z., Schöttker, B., Castro, F. A., Chen, H., Zhang, Y., Holleczek, B., & Brenner, H. (2016). Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study. Oncotarget, 7(13), 17182–17193.

de Menezes, R. F., Bergmann, A., & Thuler, L. C. S. (2013). Alcohol Consumption and Risk of Cancer: a Systematic Literature Review. Asian Pacific Journal of Cancer Prevention, 14(9), 4965–4972.

Duraker, N., Hot, S., Polat, Y., Höbek, A., Gençler, N., & Urhan, N. (2007). CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice. Journal of Surgical Oncology, 95(2), 142–147.

Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2014). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359–E386.

Goggins, M. (2007). Identifying Molecular Markers for the Early Detection of Pancreatic Neoplasia. Seminars in Oncology, 34(4), 303–310.

Haycox, Lombard, Neoptolemos, & Walley. (1998). Review article: current practice and future perspectives in detection and diagnosis of pancreatic cancer. Alimentary Pharmacology & Therapeutics, 12(10), 937–948.

Hoff, P. M. G. (2012). Tratado de Oncologia (A. Katz & R. Chammas, Eds.; 2nd ed., Vol. 8). Atheneu.

Ilic, M., & Ilic, I. (2016). Epidemiology of pancreatic cancer. World Journal of Gastroenterology, 22(44), 9694.

Instituto Brasileiro de Geografia. (n.d.). IBGE censo 2010. Retrieved March 13, 2023, from

Instituto Nacional de Câncer. (2021). Incidência de câncer no Brasil. Divisão de vigilância e análise de situação.

Jawad, Z. A. R., Theodorou, I. G., Jiao, L. R., & Xie, F. (2017). Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9. Scientific Reports, 7(1).

Korc, M., Jeon, C. Y., Edderkaoui, M., Pandol, S. J., & Petrov, M. S. (2017). Tobacco and alcohol as risk factors for pancreatic cancer. Best Practice & Research Clinical Gastroenterology, 31(5), 529–536.

Lynch, S. M., Vrieling, A., Lubin, J., Kraft, P., Hartge, P., Bueno-de-Mesquita, H. B., & Stolzenberg-Solomon, R. (2008). Cigarette Smoking And Risk Of Pancreatic Cancer: A Pooled Analysis From The Pancreatic Cancer Cohort Consortium (Panscan). Annals of Epidemiology, 18(9), 719–720.

Maisonneuve, P., & Lowenfels, A. B. (2014). Risk factors for pancreatic cancer: a summary review of meta-analytical studies. International Journal of Epidemiology, 44(1), 186–198.

McGuigan, A., Kelly, P., Turkington, R. C., Jones, C., Coleman, H. G., & McCain, R. S. (2018). Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World Journal of Gastroenterology, 24(43), 4846–4861.

Park, W., Chawla, A., & O’Reilly, E. M. (2021). Pancreatic Cancer. JAMA, 326(9), 851.

Permert, J., Adrian, T. E., Jacobsson, P., Jorfelt, L., Fruin, A. B., & Larsson, J. (1993). Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? The American Journal of Surgery, 165(1), 61–67.

Popovic, K., Smolović, B., Martinović, M., & Vučković, L. (2023). The Relationship between Diabetes Mellitus and Pancreatic Cancer—Diabetes Mellitus as a Red Flag for Pancreatic Cancer. Cancer Epidemiology, Biomarkers & Prevention, 32(3), 298–305.

Rastogi, T., Devesa, S., Mangtani, P., Mathew, A., Cooper, N., Kao, R., & Sinha, R. (2007). Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. International Journal of Epidemiology, 37(1), 147–160.

Rawla, P., Sunkara, T., & Gaduputi, V. (2019). Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World Journal of Oncology, 10(1), 10–27.

Tramacere, I., Scotti, L., Jenab, M., Bagnardi, V., Bellocco, R., Rota, M., Corrao, G., Bravi, F., Boffetta, P., & La Vecchia, C. (2010). Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. International Journal of Cancer, NA-NA.

Vrieling, A., Bueno-de-Mesquita, H. B., Boshuizen, H., & the EPIC study group, F. (2008). Abstract A98: Cigarette smoking, environmental tobacco smoke exposure, and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Cancer Prevention Research, 1(7_Supplement), A98–A98.



How to Cite

MORAIS, V. de .; PESCADOR, M. V. B. .; BROCH, L. R. .; MANTOVANI, D. .; YURK, T. C. .; TAKEMURA, A. de M. . Clinical and epidemiological profile of pancreatic cancer in Paraná between 2010 and 2018. Research, Society and Development, [S. l.], v. 12, n. 4, p. e29512441302, 2023. DOI: 10.33448/rsd-v12i4.41302. Disponível em: Acesso em: 29 may. 2024.



Health Sciences